HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Maimone, D. Articles by Reder, A. T. Search for Related Content PubMed PubMed Citation Articles by Maimone, D. Articles by Reder, A. T.

Soluble CD8 levels in the CSF and serum of patients with multiple sclerosis

Department of Neurology and the Brain Research Institute, University of Chicago, Chicago, IL.

CD8 is a membrane glycoprotein of 34 kd on cytotoxic/suppressor T lymphocytes and is an endogenous ligand for MHC class I proteins on target cells. CD8 is released in a soluble form upon T-lymphocyte activation. In multiple sclerosis (MS), T lymphocytes exhibit decreased membrane expression of the CD8 molecule and defective suppressor fonction. We measured soluble CD8 (sCD8) levels in the CSF of patients with MS, other inflammatory neurologic diseases (INDs), and noninflammatory neurologic diseases (NINDs). sCD8 levels in the CSF of MS and IND patients were elevated compared with NIND patients. Patients with acute infections of the CNS showed the highest absolute values of sCD8, but the amount of sCD8 per CSF white blood cell was greatest in MS and NIND patients. We found no difference in serum sCD8 levels among the groups. In MS, the combination of increased CSF sCD8 levels and sCD8 per cell may reflect CD8 T-lymphocyte activation within the brain or immunodysregulation confined to the CNS.

Address correspondence and reprint requests to Dr. Anthony T. Reder, Department of Neurology, University of Chicago, Box 425, 5841 South Maryland Avenue, Chicago, IL 60637.

Received August 15, 1990. Accepted for publication in final form November 9, 1990.

This article has been cited by other articles:

				R. W. Grunewald, G. M. Fiedler, B. Stock, J. M. Grunewald, and G. A. Muller Soluble CD-4 and CD-8 as markers of immunological activation in renal transplant recipients Nephrol. Dial. Transplant., January 1, 2000; 15(1): 71 - 77. [Abstract] [Full Text] [PDF]